Long-term risk of prostate cancer mortality among men with baseline prostate-specific antigen below 3 ng/ml: evidence from the finnish randomized study of screening for prostate cancer - Ola, Idris; Talala, Kirsi; Tammela, Teuvo; Taari, Kimmo; Murtola, Teemu J.; Kujala, Paula; Raitanen, Jani; Auvinen, Anssi (European urology oncology, 2025)
Online verfügbar: 6. Dezember 2024, Artikelversion: 20. März 2025